About 20 Trademarks found for “yave*”

The wording "Yaverry" has no meaning in a foreign language.

The wording "Yaveron" has no meaning in a foreign language.

The English translation of "YAVERO" in the mark is "I ALREADY SEE".

The mark consists of sharp, custom font letters, whereas the Y and R are designed to hook outwards, and the letters are designed to be closer than normal letter spacing. The word entirely, and in part, describes the body of work created and published by Alexandra Edgeworth. The word is in direct reference to copyrighted US material. Yaverse directly applies to the owned and operated website www.yaverse.com.

Downloadable electronic books in the field of fiction, namely fantasy and science fiction

Pharmaceutical preparations for injection for the treatment of Polycystic Kidney Disease (PKD); pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone

Medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of carcinoid tumours; medical devices being infusion and injection devices for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of esophageal bleeding; medical devices being infusion and injection devices for administration of pharmaceuticals for metabolic disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acromegaly; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of polycystic liver disease; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; medical devices being infusion and injection devices for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; microneedle dermal pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of carcinoid tumours; microneedle dermal pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; microneedle dermal pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of esophageal bleeding; microneedle dermal pens for administration of pharmaceuticals for metabolic disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of acromegaly; microneedle dermal pens for administration of pharmaceuticals for the treatment of polycystic liver disease; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; microneedle dermal pens for administration of pharmaceuticals intended to block growth hormone; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; devices for injection of pharmaceutical depots; devices for subcutaneous injection of pharmaceutical depot; devices for parenteral injection of pharmaceutical depot; devices for injection of pharmaceuticals and medical injection fluids; devices for injection of injection depot being pharmaceuticals; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; microneedle dermal pens for subcutaneous administration of pharmaceuticals; microneedle dermal pens for parenteral administration of pharmaceuticals; microneedle dermal pens for injection of pharmaceutical depots; microneedle dermal pens for subcutaneous injection of pharmaceutical depot; microneedle dermal pens for parenteral injection of pharmaceutical depot; microneedle dermal pens for injection of injection fluids; microneedle dermal pens for injection of injection depot; microneedle dermal pens for injections; microneedle dermal pens for medical uses

Liquor and liqueur beverages, namely, flavored distilled blue agave liquor and ready to drink distilled blue agave liquor based beverages; distilled blue agave liquor

pharmaceutical preparations for the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, the musculoskeletal system, the central nervous system, the peripheral nervous system, the genitourinary system, the respiratory system, treating dermatological disorders, hormones for medical purposes, anti-infective preparations, cytostatic preparations, allergy medication, nutrient dietary preparations adapted for medical purposes

Entertainment services, namely, providing ongoing television programs, movies , and multimedia content via satellite; providing on-line interactive computer databases in the field of entertainment information featuring television programming lists, program schedules and program- related information; providing on-line interactive computer databases featuring entertainment information and schedules about television programming, movies, and other digital images, audio, video and other multimedia materials; Entertainment services, namely, providing ongoing television programs featuring general news and local news that also include interactive functions that permit viewers to view multiple images and sources of television programming simultaneously; Entertainment services, namely, providing ongoing television programs featuring general news and local news as well as a variety of information of interest to specific geographic areas that also include interactive components that let viewers choose what to watch at various times; Entertainment services, namely, ongoing television programs in the field of geographical, categorical, real-time programming ratings that also include interactive components that let viewers more narrowly define the types of related information they receive and programs they view; Entertainment services, namely, providing ongoing television programs featuring general information relating to satellite television service, satellite television equipment and hardware, satellite television programming and audio, visual and other multimedia content that also include interactive components that allow users to define their viewing preference; On-line, non-downloadable newsletters and articles featuring general information relating to entertainment, namely, television, movies and other multimedia entertainment-related content; On-line, non-downloadable newsletters featuring general information relating to satellite telecommunication services and satellite telecommunications hardware; and entertainment services, namely, providing ongoing television programs in a wide variety of fields that also feature interactive television viewing functions that permit viewers to view and use computer applications simultaneously while viewing television programs

Entertainment services, namely, providing ongoing television programs, movies , and multimedia content via satellite; providing on-line interactive computer databases in the field of entertainment information featuring television programming lists, program schedules and program- related information; providing on-line interactive computer databases featuring entertainment information and schedules about television programming, movies, and other digital images, audio, video and other multimedia materials; Entertainment services, namely, providing ongoing television programs featuring general news and local news that also include interactive functions that permit viewers to view multiple images and sources of television programming simultaneously; Entertainment services, namely, providing ongoing television programs featuring general news and local news as well as a variety of information of interest to specific geographic areas that also include interactive components that let viewers choose what to watch at various times; Entertainment services, namely, ongoing television programs in the field of geographical, categorical, real-time programming ratings that also include interactive components that let viewers more narrowly define the types of related information they receive and programs they view; Entertainment services, namely, providing ongoing television programs featuring general information relating to satellite television service, satellite television equipment and hardware, satellite television programming and audio, visual and other multimedia content that also include interactive components that allow users to define their viewing preference; On-line, non-downloadable newsletters and articles featuring general information relating to entertainment, namely, television, movies and other multimedia entertainment-related content; On-line, non-downloadable newsletters featuring general information relating to satellite telecommunication services and satellite telecommunications hardware; and entertainment services, namely, providing ongoing television programs in a wide variety of fields that also feature interactive television viewing functions that permit viewers to view and use computer applications simultaneously while viewing television programs

fiction and non-fiction books on a variety of topics, namely science fiction and fantasy

Color is not claimed as a feature of the mark.

Computer software for mobile computing devices for use in accessing and viewing interactive television program guides via global computer networks, wireless networks and electronic communication networks; computer software for mobile computing devices for use in the remote programming of audio and video devices via global computer networks, wireless networks and electronic communication networks; computer software for the streaming of audio, video and multimedia content